RTM Vital Signs LLC
RTM Vital Signs LLC is a Philadelphia-based medical device company focused on transforming healthcare from reactive and hospital-centered to preventive, proactive, evidence-based, and person-centered. Specializing in real-time sensing, monitoring, and analysis of critical health information, RTM Vital Signs targets cardiovascular and respiratory health. The company leverages proprietary, cost-effective monitoring technology, advanced sensors, and AI-driven diagnostic algorithms to provide continuous, real-time health status tracking for both hospital and ambulatory patients. Their mission is to enable better health outcomes, lower costs, and improve patient and staff experiences through innovative wearable devices and continuous monitoring solutions. RTM's patented solutions are designed for seamless integration with smart devices and wearables, supporting timely diagnosis, predictive analytics, and improved telemedicine capabilities. Their technology also addresses key public health challenges such as hypertension, respiratory compromise, and opioid-induced respiratory depression, with applications extending to fitness, industrial safety, and veterinary medicine.
Industries
Nr. of Employees
small (1-50)
RTM Vital Signs LLC
Pennovation Center, 3401 Grays Ferry Avenue, Bldg 450, Philadelphia, PA 19146-2701
Patents
Products
Wearable respiratory monitoring system (FDA‑cleared device)
Non‑invasive wearable system that continuously measures respiratory rate, displays respiratory waveforms over time, and provides real‑time alerts for use by healthcare professionals and in ambulatory and research settings.
Acoustic ventilation monitoring prototype
Prototype using tracheal acoustic sensing and signal processing to monitor ventilation and estimate tidal volume without masks or direct airflow sensors.
Ambulatory cardiac and fitness monitoring module
Wearable system designed to capture cardiac‑related vital signs alongside respiratory‑derived fitness metrics such as minute ventilation for ambulatory and fitness applications.
Implantable cardiac monitoring system (prototype)
Long‑term implantable sensor system that continuously measures detailed arterial blood pressure waveforms and records ECG; system data are intended to feed predictive algorithms for diagnostics, medication dosing, and event prediction.
Wearable respiratory monitoring system (FDA‑cleared device)
Non‑invasive wearable system that continuously measures respiratory rate, displays respiratory waveforms over time, and provides real‑time alerts for use by healthcare professionals and in ambulatory and research settings.
Acoustic ventilation monitoring prototype
Prototype using tracheal acoustic sensing and signal processing to monitor ventilation and estimate tidal volume without masks or direct airflow sensors.
Ambulatory cardiac and fitness monitoring module
Wearable system designed to capture cardiac‑related vital signs alongside respiratory‑derived fitness metrics such as minute ventilation for ambulatory and fitness applications.
Implantable cardiac monitoring system (prototype)
Long‑term implantable sensor system that continuously measures detailed arterial blood pressure waveforms and records ECG; system data are intended to feed predictive algorithms for diagnostics, medication dosing, and event prediction.
Expertise Areas
- Continuous respiratory monitoring
- Implantable arterial pressure monitoring
- Wearable and implantable sensor hardware design
- Signal processing and machine‑learning for biosignals
Key Technologies
- Wearable physiological sensors
- Acoustic respiration sensing
- Tidal‑volume estimation and minute ventilation computation
- Respiratory rate detection
Key People
News & Updates
RTM Vital Signs received First Prize for Innovation at the 2023 American Society of Anesthesiology Conference, recognizing its breakthrough in respiratory monitoring technology.
RTM Vital Signs was recognized with the TechConnect Defense Innovation Award in 2019 for its innovative technology.
RTM's technology received the FDA Breakthrough Device Designation, highlighting its innovative approach to respiratory monitoring.
RTM has been awarded two NIH grants to support clinical trials and technology development.
RTM was chosen as a case study for MIT’s Entrepreneurship Bootcamp, recognizing its innovation and business model.
A white paper discussing how continuous clinical surveillance can help clinical teams proactively anticipate early signs of opioid-induced respiratory depression, sepsis, and other hospital-acquired conditions by capturing a real-time portrait of a patient’s condition.
RTM Vital Signs received First Prize for Innovation at the 2023 American Society of Anesthesiology Conference, recognizing its breakthrough in respiratory monitoring technology.
RTM Vital Signs was recognized with the TechConnect Defense Innovation Award in 2019 for its innovative technology.
RTM's technology received the FDA Breakthrough Device Designation, highlighting its innovative approach to respiratory monitoring.
RTM has been awarded two NIH grants to support clinical trials and technology development.
RTM was chosen as a case study for MIT’s Entrepreneurship Bootcamp, recognizing its innovation and business model.
A white paper discussing how continuous clinical surveillance can help clinical teams proactively anticipate early signs of opioid-induced respiratory depression, sepsis, and other hospital-acquired conditions by capturing a real-time portrait of a patient’s condition.